India criticises $300 bn climate finance target at COP29
Developing and poorer nations most at the frontline of worsening disasters dismissed the $300 billion a year pledge from wealthy historic polluters as insultingly low.
A screen displays Chandni Raina of India, as she speaks during a closing plenary meeting at the COP29 United Nations Climate Change Conference, in Baku, Azerbaijan November 24, 2024. (Photo: Reuters)
By EasternEyeNov 25, 2024
INDIA rejected a bitterly negotiated climate deal on Sunday (24), when countries at the COP29 summit in Baku adopted a $300 billion a year global finance target to help poorer nations cope with impacts of climate change.
After two exhausting weeks of chaotic bargaining and sleepless nights, nearly 200 nations pushed through the contentious finance pact in the early hours in a sports stadium in Azerbaijan.
However, developing and poorer nations most at the frontline of worsening disasters dismissed the $300 billion a year pledge from wealthy historic polluters as insultingly low.
"It's a paltry sum," thundered India's delegate Chandni Raina.
"This document is little more than an optical illusion. This, in our opinion, will not address the enormity of the challenge we all face."
Raina, an adviser at India’s Department of Economic Affairs, described the adoption process as "unfair" and "stage-managed" and added that it reflected the troubling lack of trust in the UN system.
Throughout COP29, developed nations - major economies like the European Union, the US and Japan - were accused of negotiating in bad faith, making a fair deal impossible.
Sierra Leone's climate minister Jiwoh Abdulai said the final agreement showed a "lack of goodwill" from rich countries to stand by the world's poorest as they confront rising seas and harsher droughts.
Nigeria's envoy Nkiruka Maduekwe put it even more bluntly: "This is an insult."
Nations had struggled at COP29 to reconcile long-standing divisions over how much developed nations most accountable for historic greenhouse gas pollution should provide to poorer countries least responsible but most impacted by earth's rapid warming.
The meeting also saw stalling on the promise to "transition away" from fossil fuels, the main driver of global heating.
That pledge, a key achievement of COP28 in Dubai, was scrubbed from the final Baku deal.
US president Joe Biden cast the agreement reached in Baku as a "historic outcome", while EU climate envoy Wopke Hoekstra said it would be remembered as "the start of a new era for climate finance".
UK energy secretary Ed Miliband hailed "a critical eleventh-hour deal at the eleventh hour for the climate".
However, the Least Developed Countries bloc of 45 nations slammed the COP29 outcome as a "travesty", adding that it failed to make progress on curbing warming, or deliver enough cash to protect the most vulnerable.
"This is not just a failure; it is a betrayal," the group said in a statement.
India said its request to speak before the adoption of the climate finance package was ignored.
"We had informed the presidency and the secretariat that we wanted to make a statement before any decision on the adoption. However, and this is for everyone to see, this has been stage-managed, and we are extremely disappointed with this incident," Raina said.
"We have seen what you have done. However, we would want to say that gavelling and trying to ignore parties from speaking does not behove of the UNFCCC (United Nations Framework Convention on Climate Change) system, and we would want you to hear us and also hear our objections to this adoption. We absolutely object to this," the Indian official said, drawing loud applause in a plenary full of diplomats, civil society members and journalists.
Only trust and collaboration can drive meaningful action against climate change, which is one of humanity’s greatest existential challenges, Raina said.
"It's a fact that both (trust and collaboration) have not worked today and we are deeply hurt by the actions of the presidency and the (UNFCCC) Secretariat," she added.
India said the new climate finance package of a “meagre” $300bn annually by 2035 is "too little and too distant" and it does not accept it in its present form.
Malawi and Bolivia also lent support to India.
Raina said the outcome clearly reflects the unwillingness of developed countries to fulfil their responsibilities.
Nations have agreed to try to limit temperature rise to 1.5 degrees Celsius above preindustrial times. Currently the world is on track for devastating warming of between 2.6C and 3.1C this century, according to the UN.
UN Secretary-General Antonio Guterres said he had "hoped for a more ambitious outcome" and appealed to governments to see it as a starting point.
Developed countries only put the $300 billion figure on the table on Saturday after COP29 went into extra time and diplomats worked through the night to improve an earlier spurned offer.
At points, the talks appeared on the brink of collapse.
Delegates stormed out of meetings, fired shots across the bow, and threatened to walk away from the negotiating table should rich nations not cough up more cash.
In the end - despite repeating that "no deal is better than a bad deal" - developing nations did not stand in the way of an agreement.
The agreement commits developed nations to pay at least $300 billion a year by 2035 to help developing countries cut emissions and prepare for worsening disasters.
It falls short of the $390bn that economists commissioned by the United Nations had deemed a fair share contribution by developed nations.
The US and EU pushed to have newly wealthy emerging economies like China - the world's largest emitter - chip in.
Wealthy nations said it was politically unrealistic to expect more in direct government funding at a time of geopolitical uncertainty and economic belt-tightening.
The deal also posits a larger overall target of $1.3 trillion per year to cope with rising temperatures and disasters, but most would come from private sources.
The hope is that the money from developed countries will help boost private investment to reach an ambitious goal - written into the deal - of delivering at least $1.3 trillion per year by the next decade.
The showdown over financing for developing countries comes in a year scientists predict will be the hottest on record.
Climate woes are stacking up, with widespread flooding killing thousands across Africa, deadly landslides burying villages in Asia, and drought in South America shrinking rivers.
Developed countries have not been spared. Torrential rain triggered floods in Valencia, Spain, last month that left more than 200 dead, and the US so far this year has registered 24 billion-dollar disasters - just four fewer than last year.
UK life sciences sector contributed £17.6bn GVA in 2021 and supports 126,000 high-skilled jobs.
Inward life sciences FDI fell by 58 per cent from £1,897m in 2021 to £795m in 2023.
Experts warn NHS underinvestment and NICE pricing rules are deterring innovation and patient access.
Investment gap
Britain is seeking to attract new pharmaceutical investment as part of its plan to strengthen the life sciences sector, Chancellor Rachel Reeves said during meetings in Washington this week. “We do need to make sure that we are an attractive place for pharmaceuticals, and that includes on pricing, but in return for that, we want to see more investment flow to Britain,” Reeves told reporters.
Recent ABPI report, ‘Creating the conditions for investment and growth’, The UK’s pharmaceutical industry is integral to both the country’s health and growth missions, contributing £17.6 billion in direct gross value added (GVA) annually and supporting 126,000 high-skilled jobs across the nation. It also invests more in research and development (R&D) than any other sector. Yet inward life sciences foreign direct investment (FDI) fell by 58per cent, from £1,897 million in 2021 to £795 million in 2023, while pharmaceutical R&D investment in the UK lagged behind global growth trends, costing an estimated £1.3 billion in lost investment in 2023 alone.
Richard Torbett, ABPI Chief Executive, noted “The UK can lead globally in medicines and vaccines, unlocking billions in R&D investment and improving patient access but only if barriers are removed and innovation rewarded.”
The UK invests just 9% of healthcare spending in medicines, compared with 17% in Spain, and only 37% of new medicines are made fully available for their licensed indications, compared to 90% in Germany.
Expert reviews
Shailesh Solanki, executive editor of Pharmacy Business, pointed that “The government’s own review shows the sector is underfunded by about £2 billion per year. To make transformation a reality, this gap must be closed with clear plans for investment in people, premises and technology.”
The National Institute for Health and Care Excellence (NICE) cost-effectiveness threshold £20,000 to £30,000 per Quality-Adjusted Life Year (QALY) — has remained unchanged for over two decades, delaying or deterring new medicine launches. Raising it is viewed as vital to attracting foreign investment, expanding patient access, and maintaining the UK’s global standing in life sciences.
Guy Oliver, General Manager for Bristol Myers Squibb UK and Ireland, noted that " the current VPAG rate is leaving UK patients behind other countries, forcing cuts to NHS partnerships, clinical trials, and workforce despite government growth ambitions".
Reeves’ push for reform, supported by the ABPI’s Competitiveness Framework, underlines Britain’s intent to stay a leading hub for pharmaceutical innovation while ensuring NHS patients will gain faster access to new treatments.
By clicking the 'Subscribe’, you agree to receive our newsletter, marketing communications and industry
partners/sponsors sharing promotional product information via email and print communication from Garavi Gujarat
Publications Ltd and subsidiaries. You have the right to withdraw your consent at any time by clicking the
unsubscribe link in our emails. We will use your email address to personalize our communications and send you
relevant offers. Your data will be stored up to 30 days after unsubscribing.
Contact us at data@amg.biz to see how we manage and store your data.